Arrhythmias & electrophysiologyRandomised controlled trial
Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study
- Study protocol of a cluster-randomised prospective cohort study
- cluster-randomised (16 primary clinics)
Authors' conclusion
The STROKESTOP III study will provide valuable information on which screening method to use for improved participation in atrial fibrillation screening.
Study context
- Population
- 75–76-year-old individuals served by 16 primary clinics in Värmland, Sweden
- Participants
- 2,954 individuals · 16 primary clinics
- Comparison
- Opportunistic screening vs population screening for atrial fibrillation (AF)
- Primary endpoint
- Rate of participation in AF screening
Primary result
As reported in the abstract
- Protocol; no results reported
Original publication
Increasing the reach: optimizing screening for atrial fibrillation—the STROKESTOP III study. Europace. Published 20 September 2024. doi:10.1093/europace/euae234
Summarised from the published abstract; every number is checked against it